Log In
Print
BCIQ
Print
Print this Print this
 

Sabutoclax (ONT-701)

  Manage Alerts
Collapse Summary General Information
Company Oncothyreon Inc.
DescriptionSmall molecule pan-inhibitor of B cell lymphoma 2 (BCL-2; BCL2) proteins
Molecular Target B cell lymphoma 2 (BCL-2) (BCL2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today